Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank21
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-3.54
↑ 39% vs avg
Percentile
P21
Within normal range
Streak
2 yr
Consecutive declineElevated
Average
-5.84
Historical baseline
PeriodValueYoY Change
2024-3.54-108.9%
2023-1.69-47.0%
2022-1.15+79.8%
2021-5.70-158.2%
2020-2.21-69.2%
2019-1.31-302.3%
2018-0.32+35.4%
2017-0.50-118.7%
2016-0.23+99.4%
2015-41.74-